Nerve Tape® Study led by Top Surgeons Receives Distinction
February 14, 2024 17:10 ET
|
BioCircuit Technologies
Atlanta, GA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- BioCircuit Technologies, an NIH-supported company in Atlanta, GA, recently announced the publication of an independent study assessing Nerve Tape, the...
Discoverer of the Klotho Gene and Pioneer in Longevity and Disease Prevention Dr. Makoto Kuro-o Joins Scientific Advisory Board of ADvantage Therapeutics
February 05, 2024 09:41 ET
|
Advantage Therapeutics Inc.
BOCA RATON, Fla. and VIENNA, Austria, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, a pioneer in developing therapies for neurodegenerative conditions by addressing the biology of aging,...
CARGO Therapeutics Announces Scientific Advisory Board
December 06, 2023 08:05 ET
|
Cargo Therapeutics, Inc.
SAN MATEO, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (CRGX), a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell...
Polymerase chain reaction Market Size Worth USD 19.24 Billion in 2032 | Emergen Research
November 21, 2023 10:00 ET
|
Emergen Research
Vancouver, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market size was USD 8.50 Billion in 2022 and is expected to register a revenue CAGR of 8.5% during the...
IBA déclaration intermédiaire - Troisième trimestre 2023
November 16, 2023 01:00 ET
|
IBA SA
Louvain-la-Neuve, Belgique, le 16 novembre 2023 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, publie aujourd'hui la revue de ses...
IBA Business Update – Third Quarter 2023
November 16, 2023 01:00 ET
|
IBA SA
Louvain-La-Neuve, Belgium, 16 November 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its business update for the third quarter...
Tomi Environmental Solutions, Inc. Reports Third Quarter Financial Results
November 14, 2023 16:05 ET
|
TOMI Environmental Solutions, Inc.
FREDERICK, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its...
Tonix Pharmaceuticals Announces Enrollment Initiated in Mass General Brigham Phase 2 Investigator-Initiated Study of TNX-1900 (Intranasal Potentiated Oxytocin) for Bone Health in Children with Autism Spectrum Disorder
November 13, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Children with Autism Spectrum Disorder are at Risk for Low Bone Density Preliminary Data Suggest that the Administration of Oxytocin May Favorably Impact Bone Formation and Strength Recent...
Tonix Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Highlights
November 09, 2023 16:15 ET
|
Tonix Pharmaceuticals Holding Corp.
Topline Results from Phase 3 Potentially NDA-Enabling Study of TNX-102 SL in Fibromyalgia Expected Late December 2023: Centrally-Acting Non-Opioid Analgesic Topline Results from Phase 2...
Tonix Pharmaceuticals Announces New Data Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) in Heart Xenotransplantation in Animal Models at the ACS Clinical Congress and IPITA-IXA-CTRMS Joint Congress
October 30, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital TNX-1500 is currently in Phase 1 Clinical Development Tonix is Developing TNX-1500 for...